Michael Milane, MD, MBA

Greenway Therapeutix

President & CEO



Dr. Milane has 12 years of Pharmaceutical industry experience in clinical development and medical affairs. He has served as a physician executive in multiple pharmaceutical companies, including working with companies such as Galderma, Sun Pharma (DUSA), Taro and Merck, where he has developed high-level scientific programs, various research studies and educational resources with a multitude of organizations in Dermatology. In his most recent role as a CMO, he assisted in raising capital and developed the medical strategy that grew a start-up company to a successful NASDAQ IPO in 2018, worth over $300M. 

Previous to his industry roles, Dr. Milane served as a fellow with the NIH and faculty at UCLA Medical Center with residency training at UCLA and medical training at Tulane School of Medicine with a combined MD/MPH degree. He completed his Health Care Executive MBA training in 2010 from UC Irvine's Merage School of Business in further developing the leadership and other business skills to manage industry needs in an appropriate and responsible medical capacity for the development of cutting edge and fiscally responsible therapies and advancements in Dermatology.

Practical Symposium 2022 | Beaver Creek, CO